Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Retained Earnings: 2010-2025

Historic Retained Earnings for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to $1.1 billion.

  • BIO-TECHNE's Retained Earnings fell 19.28% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 19.28%. This contributed to the annual value of $1.1 billion for FY2025, which is 19.56% down from last year.
  • Latest data reveals that BIO-TECHNE reported Retained Earnings of $1.1 billion as of Q3 2025, which was up 1.55% from $1.1 billion recorded in Q2 2025.
  • BIO-TECHNE's 5-year Retained Earnings high stood at $1.3 billion for Q3 2024, and its period low was $1.1 billion during Q2 2025.
  • In the last 3 years, BIO-TECHNE's Retained Earnings had a median value of $1.3 billion in 2024 and averaged $1.2 billion.
  • As far as peak fluctuations go, BIO-TECHNE's Retained Earnings rose by 16.61% in 2023, and later dropped by 19.56% in 2025.
  • BIO-TECHNE's Retained Earnings (Quarterly) stood at $1.1 billion in 2021, then rose by 4.74% to $1.2 billion in 2022, then rose by 5.12% to $1.3 billion in 2023, then grew by 2.01% to $1.3 billion in 2024, then decreased by 19.28% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q3 2025, $1.1 billion for Q2 2025, and $1.2 billion during Q1 2025.